Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Forette

Showing results (61-70 of 128) with videos related to

Pageof 13
Sort By:
The Journal of Nutrition, Health & Aging|October 8, 2013
The therapeutic management of chronic pain in ambulatory care patients aged 65 and over in France: the S.AGES Cohort. Baseline dataP Bertin, L Becquemont, E Corruble, et al.
Annales De Cardiologie Et D'Angeiologie|February 1, 1987
[Arterial hypertension in the elderly. Double-blind study versus placebo of the efficacy and tolerability of an alpha-beta blocker: labetalol]F Forette, M Henry-Amar, H d'Allens, et al.
British Journal of Clinical Pharmacology|January 1, 1985
Effect of nicardipine in elderly hypertensive patientsF Forette, M Bellet, J F Henry, et al.
European Journal of Neurology|April 22, 1999
In vivo PET study of cerebral [11C] methyl- tetrahydroaminoacridine distribution and kinetics in healthy human subjectsL Traykov, B Tavitian, A Jobert, et al.
Archives of Neurology|September 1, 1993
Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging studyC A Cuénod, A Denys, J L Michot, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 15, 2000
[Cognitive impairment and dementia in hypertension; the effect of antihypertensive medication]W H Birkenhäger, P W de Leeuw, J A Staessen, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1989
Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindoprilF Forette, J McClaran, M C Delesalle, et al.
Psychopharmacology|January 1, 1980
Comparison of single-dose pharmacokinetics of imipramine and maprotiline in the elderlyP D Hrdina, V Rovei, J F Henry, et al.
The Journal of Nutrition, Health & Aging|November 7, 2007
Healthy working life expectancies at age 50 in Europe: a new indicatorA Lievre, F Jusot, T Barnay, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 1, 1989
[Significance of inhibitors of conversion enzymes in elderly subjects. The example of perindopril]F Forette, J M McClaran, M C Delesalle, et al.
Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
The Journal of Nutrition, Health & Aging|October 8, 2013
The therapeutic management of chronic pain in ambulatory care patients aged 65 and over in France: the S.AGES Cohort. Baseline dataP Bertin, L Becquemont, E Corruble, et al.
Annales De Cardiologie Et D'Angeiologie|February 1, 1987
[Arterial hypertension in the elderly. Double-blind study versus placebo of the efficacy and tolerability of an alpha-beta blocker: labetalol]F Forette, M Henry-Amar, H d'Allens, et al.
British Journal of Clinical Pharmacology|January 1, 1985
Effect of nicardipine in elderly hypertensive patientsF Forette, M Bellet, J F Henry, et al.
European Journal of Neurology|April 22, 1999
In vivo PET study of cerebral [11C] methyl- tetrahydroaminoacridine distribution and kinetics in healthy human subjectsL Traykov, B Tavitian, A Jobert, et al.
Archives of Neurology|September 1, 1993
Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging studyC A Cuénod, A Denys, J L Michot, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 15, 2000
[Cognitive impairment and dementia in hypertension; the effect of antihypertensive medication]W H Birkenhäger, P W de Leeuw, J A Staessen, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1989
Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindoprilF Forette, J McClaran, M C Delesalle, et al.
Psychopharmacology|January 1, 1980
Comparison of single-dose pharmacokinetics of imipramine and maprotiline in the elderlyP D Hrdina, V Rovei, J F Henry, et al.
The Journal of Nutrition, Health & Aging|November 7, 2007
Healthy working life expectancies at age 50 in Europe: a new indicatorA Lievre, F Jusot, T Barnay, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 1, 1989
[Significance of inhibitors of conversion enzymes in elderly subjects. The example of perindopril]F Forette, J M McClaran, M C Delesalle, et al.
Pageof 13